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“Specialized ribosomes” is a topic of intense debate and research whose provenance can be traced to the
earliest days of molecular biology. Here, the history of this idea is reviewed, and critical literature in which the
specialized ribosomes have come to be presently defined is discussed. An argument supporting the evolution
of a variety of ribosomes with specialized functions as a consequence of selective pressures acting on a
near-infinite set of possible ribosomes is presented, leading to a discussion of how this may also serve as a
biological buffering mechanism. The possible relationship between specialized ribosomes and human health
is explored. A set of criteria and possible approaches are also presented to help guide the definitive
identification of “specialized” ribosomes, and this is followed by a discussion of how synthetic biology
approaches might be used to create new types of special ribosomes.
© 2015 The Author. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).In the Beginning
By 1959, it was known that genetic information is
encoded by nucleic acids and that proteins are
synthesized by RNA-rich ribosomes. This led Fran-
cis Crick to suggest that the each ribosome contains
a unique RNA encoding a single gene: the “one
gene–one ribosome–one protein” hypothesis [1]. A
year later at the so-called “Good Friday Meeting” [2],
Jacob, Brenner and Crick realized that a previously
described unstable DNA-like RNA of T2 phage [3,4]
possessed the properties of an intermediate re-
quired for protein synthesis. This conceptual break-
through catalyzed the discovery of mRNA (reviewed
in Ref. [5]). However, that germ of an idea, that is,
the notion that heterogeneity may confer special
properties upon ribosomes, has remained alluring.
Indeed, the ribosomes of extremophiles such as
Haloarcula marismortui or Thermus thermophilus
are specialized to optimally perform protein synthe-
sis in high-salt and high-temperature environments,
properties that were critical to their characterization
by X-ray crystallography [6]. Similarly, mitochondrial,
chloroplastid and other organellar ribosomes haveAuthor. Published by Elsevier Ltd. This
rg/licenses/by-nc-nd/4.0/).evolved to optimally translate limited genomes in
specialized intracellular niches. Thus, technically,
yes, special ribosomes are known to exist and the
discussion could conclude here. However, the
general idea that ribosomes may be fine-tuned to
translate specific mRNAs and/or have special
properties in specific cell types and/or in response
to certain environmental cues is commonly what is
understood by the term “specialized ribosome”. With
this in mind, this essay first explores the idea of
specialized ribosomes. It is not intended to be an
exhaustive review of the subject: readers interested
in a deep investigation of the evidence supporting
specialized ribosomes are directed to the outstand-
ing review by Xue and Barna [7] serving to define
the state of the art in this field. Rather, this essay
seeks to contribute an additional perspective to this
fundamental question in the field of molecular
genetics. This includes an evolutionary argument in
favor of ribosome heterogeneity, a discussion of the
consequences of disruption of ribosomal homeosta-
sis and a summary of the challenges that must
be overcome in order to definitively demonstrate
the existence of specialized ribosomes. A final set ofis an open access article under the CC BY-NC-ND license
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classical discovery science and synthetic biology.First Inklings: The Hunt for Special
Ribosomes and Hints Regarding Where
They May Be Found
One early hypothesis was that differences in
between natural and laboratory environments might
exert differential selective pressures upon ribo-
somes within a species and that this might facilitate
identification of ribosomes with specialized proper-
ties. A test of this hypothesis revealed that the
enhanced growth and survival phenotypes of natu-
rally occurring Escherichia coli relative to laboratory
strains correlated with enhanced interactions
between ribosomes and ternary complex [8]. While
these findings showed that the ribosomes of
laboratory strains have “devolved” relative to their
wild-type counterparts, it is also consistent with the
notion that ribosomal diversity is selected for under
natural conditions. More recent studies in bacterial
systems have examined the possibility that ribosome
specialization might be achieved by differential
post-translational modification of ribosomal proteins.
Two such studies revealed that such modifications
may contribute to maintenance of stationary phase
[9] and stress-adapted cell growth [10].
In contrast to bacteria, the compartmentalized
subcellular structures and complex developmental
pathways of eukaryotes present richer environments
in which to hunt for ribosomes with special properties.
The yeast Saccharomyces cerevisiae has historically
served as a robust geneticmodel for identification and
characterization of gene function. The whole genome
of yeast was duplicated approximately 200 million
years ago [11,12]. Although nearly 90% of the
duplicated genes were eliminated between then and
the present, ribosomal protein genes remain over-
represented among the 457 remaining paralogous
gene pairs. One possible explanation is that the
different protein paralogs may confer differential
properties upon ribosome. Perhaps the first evidence
supporting this idea came from genetic screens
performed in the late 1970s and in early 1980s for
mutants no longer capable of supporting replication of
the endogenous “Killer” virus; this approach identified
a large family of genes named MAintenance of Killer
(MAK). Gene ontology analysis reveals enrichment in
two general functions among the MAK genes:
N-terminal protein maturation and modification and
the large ribosomal subunit (biogenesis, maturation
and integral ribosomal proteins). The first class of
MAKgenes is explained by the requirement of the viral
capsid protein for a specific type of N-terminal
modification [13,14], while the latter points to the
ribosome. Intriguingly, MAK7 and MAK18 are alsoknown as RPL8A and RPL42B, which encode
ribosomal proteins L8A and L42B (also known as
eL8A and eL42B [15]). Curiously, only deletion of
these genes, but not of their paralogs (RPL8B or
RPL42A), promoted the Mak− phenotype [16,17],
suggesting that these proteins, and not their paralogs,
are specifically required to translate themRNAs of this
virus family, which lack 5′ cap structures and polyA
tails. Since then, additional genetic studies in yeast
revealed similar ribosomal protein paralog-specific
phenotypes. For example, a large-scale screen for
yeast mutants unable to support replication of the
yeast Ty1 retrotransposable element revealed 87 Ty1
co-factormutants, 8 of which corresponded to one, but
not the other paralog of a ribosomal protein-encoding
gene [18]. A more wide ranging study that screened
theentire collection of yeast ribosomal protein deletion
mutants identified paralog-specific differences with
regard to a large number of cellular and metabolic
functions including localized mRNA translation, drug
sensitivity/resistance and macromolecular assembly
and localization [19]. Another study applied a series of
comparative protein synthesis assays to the gene
deletion collection, identifying paralog-specific differ-
ences in translational accuracy [20]. In unpublished
studies, my laboratory is currently investigating
ribosomal protein paralog-specific differences in
translational fidelity. However, as discussed below,
while these studies provide evidence for the existence
of ribosomes with ribosomal protein paralog-specific
phenotypes, they do not provide direct evidence for
specialized ribosomes.
Breakthrough: The complex developmental
programs of metazoan organisms provide rich
hunting grounds for specialized ribosomes
A growing number of genetic approaches support
the hypothesis of ribosome specialization through
differential expression of ribosomal genes or ribo-
somal gene-like paralogs over a broad range of
functions in many organisms. These are reviewed in
Ref. [7]. Perhaps the most important breakthrough
came from studies of development in mice revealing
tissue-specific patterns of RPL38 expression during
embryogenesis in a manner that overlaps with
embryonic tissues that are affected by loss of
function of the eukaryote-specific ribosomal protein
eL38 [21]. This was followed by an unbiased
large-scale expression profiling screen in developing
mouse embryos revealing significant differences
among different cell types and tissues in the
expression of ribosomal protein mRNAs and reveal-
ing that groups of ribosomal protein mRNAs were
co-regulated [21]. These observations, plus the prior
observation that eL38 is predominantly expressed in
the pancreatic ductal epithelium in adult mice [22],
brought into question the common assumption that
all core ribosomal proteins are stoichiometrically
2188 Perspective: Pathways to Specialized Ribosomesexpressed, suggesting the possibility of cell-type-
specific and tissue-type-specific ribosome heteroge-
neity. These studies led to a concrete definition of
what is meant by specialized ribosomes: those in
which “…a unique composition or specialized activity
confer(s) regulatory control in gene expression” [7].
That the lack of eL38 results in a well-defined
homeotic transformation and that this correlates with
eL38 requiring IRES's in specific Hox mRNAs [23]
may be akin to the requirement for ribosomal protein
eL30 to recruit SECIS elements for eukaryotic
selenoprotein mRNA recoding [24]. In this case,
ribosome-associated eL38 may act as receptor for
an RNA ligand (Hox) only in the neural tube and
somites, while in the prostate where eL38 is not
expressed, ribosomes may possess a different
receptor (another ribosomal protein? A trans-acting
protein or RNA?) to engage a different RNA ligand.
While this somewhat indirectly supports the special-
ized ribosome hypothesis, it raises a chicken versus
egg conundrum. Did the IRES's in these mRNAs
evolve so as to capitalize on the presence of eL38 in
eukaryotic ribosomes as a means to participate in a
receptor (eL38) ligand (the IRES) interaction to recruit
thesemRNAs to ribosomes or did eL38 evolve later, in
response to the more complex vertebrate develop-
mental program? Finally, it should be noted that the
demonstration of tissue-specific differences in ribo-
somal protein mRNA expression does not prove the
existence of specialized ribosomes. As discussed
below, biochemical/biophysical approachesare need-
ed to follow up on these exciting genetic studies.
Human health and the specialized ribosome:
Inherited and acquired diseases
An apparent paradox known as Dameshek's
Riddle [25] is used to describe a class of patients
who initially present with too few of a specific type of
blood cell but in which survivors of this phase of the
disease are at higher risk of developing diseases
involving over-production of the same type of cell.
The first identification of the gene responsible for one
of these diseases, Diamond-Blackfan anemia, was
the ribosomal protein coding gene RPS19 [26]
(encoding eS19 [15]), leading this class of diseases
to be termed “ribosomopathies”. The list of riboso-
mopathies has expanded to include diseases
caused by mutations in genes that encode ribosomal
proteins, ribosome biogenesis factors and the
machinery that modifies ribosomal RNAs (reviewed
in Refs. [27–31]). Intriguingly, while all of these
diseases originate with the ribosome, each has its
unique clinical presentation: this is consistent with a
model in which different cell/tissue types may require
different types of ribosomes. More recently, associ-
ations between somatically acquired mutations in
ribosomal protein genes and a variety of cancers
have been established. These include the genesencoding ribosomal protein L5 (RPL5/uL18), RPL11/
uL5, RPL10/uL16 and RPL22/eL22 [32–37]. Excit-
ingly, the comprised translational efficiency of
GATA1 mutants, a critical hematopoietic transcrip-
tion factor with a highly structured 5′ untranslated
region in Diamond-Blackfan anemia [38], and
important studies on dyskerin that link rRNA
modification and IRES-dependent translation in
ribosomopathies [39], as well as differences in the
actual pattern of rRNA modifications in patients [40],
provide robust models for recapitulating ribosomo-
pathies at the organismal level, opening windows
into understanding how gene expression is affected
in these syndromes. However, it should be noted
that, while associations between specific ribosomal
proteins and particular cancers are consistent with
the idea that different tissues may require different
populations of ribosomes, no studies have produced
spec ia l i z ed r i bosomes fo r b i ochem ica l
characterization.
An evolutionary argument for specialized
ribosomes
The very language that we use to refer to the
ribosome implies the image of a monolithic machine.
For example, a Google search for the term “the
ribosome is” yielded approximately 3,130,000 re-
sults compared to 952,000 results for “ribosomes
are”. We persist with this conceptual construct
despite the fact that there is no basis in empirical
evidence for this view [29]. Indeed, it is unrealistic to
assume that the evolutionary process has selected
for a unique macromolecule that has been maxi-
mized for its ability to translate a near-infinite number
of mRNAs in response to a near-infinite number of
stimuli. Evolution is a process in which diverse
populations are acted upon by selective pressures.
Explicit in this is that selection for specialized
function is maximized as the potential for diversity
is increased. With this in mind, let us explore
potential sources of diversity in ribosomes (limiting
the discussion to only one species, humans, so as
not to conflate interspecific differences with the
definition of specialized ribosomes described
above). First, consider that the diploid human
genome encodes a minimum of two copies of at
least 80 ribosomal protein genes [41]. Because the
ribosome is so central to cellular function, it is
commonly assumed that there is little to no allelic
diversity among the human ribosomal protein genes.
However, a cursory analysis of single nucleotide
polymorphisms in the core and essential RPL3 gene
encoding ribosomal protein uL3 in the NCBI dbSNP
database† revealed over 100 annotated missense
alleles in its protein coding region alone, suggesting
that there is a significant amount of allelic diversity
among human ribosomal proteins. (Call to action:
someone should undertake systematic analysis of
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genome of each individual human has the capacity
to encode
 80
2

(i.e., 80 choose 2 = 3160) unique
ribosomes based on protein content alone. Addition-
al potential for a very large amount of diversity in
ribosomes comes from the fact that at least 212
modified bases have been identified in the four
human rRNAs [42]. Thus, cells are theoretically
capable of generating an astounding 212! unique
rRNAs (a number that is approximately 4 followed by
360 zeros). Multiply these by an unknown number of
post-translational ribosomal protein modifications
and transiently associated proteins and factors,
and the total possible number of unique ribosomes
is practically limitless. These numbers suggest a
system with the capacity to generate a highly diverseOptimized for
“environment” A
Optimize
“environm
Localization
(a) (b)
(c) (d)
Fig. 1. “The Ribosome” as a diverse collection of non-ident
ribosomes is represented as grey-outlined small circles. These
including processivity, structure, affinities for various ligands
reactions (Kcat), translational accuracy, localization (subce
Ribosomes occupying the “Habitable Zone” are those that a
Ribosome” is defined as all possible ribosomes occupying th
provides a well-buffered system. (c and d) Different distributi
apparatus for different environments. (e) Expression of defec
results in disease (ribosomopathies). Ribosomapathies may a
ribosomes due to the decreased expression of one or more riset of variations of the same machine, each
endowed with its own idiosyncratic properties.
With these ideas in mind, I propose that the
evolutionary processhashadanearly limitless number
of potential ribosomes upon which to select for
specialized function (Fig. 1). “The Ribosome” can be
visualized as a cloud of potential individuals capable of
occupying an n-dimensional space. First, consider
ribosomes as they occupy the standard four dimen-
sions (x, y and z spatial axes plus t = time). At this
level, ribosome heterogeneity is already beginning to
be revealed at the quantum level; approximately 50
metastable free-energy states havebeendescribed for
ribosomes [43]. Furthermore, a recent analysis reveal-
ing that these may follow a distinct and closed set of
low-energy trajectories through the free-energy land-
scape [44] can be interpreted as evidence of selective    Ribosome Diversity 
Even distribution = Buffering
d for
ent” B Disease state
(e)
ical individuals. (a) The nearly infinite universe of possible
can be characterized in n-dimensional space along axes
(KD), ability to directly or indirectly catalyze enzymatic
llular, tissue and/or development specific) and speed.
re capable of supporting vital cellular functions. (b) “The
e habitable zone. Evenly distributed throughout the zone
ons of ribosomes enable optimization of the translational
tive ribosomes lying outside of the habitable zone leads
lso result from depletion of a particular type of ribosome or
bosomal protein genes.
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pressures, can be further expanded to include and
operate along additional axes. Examples include
affinities for different ligands, ranges of catalytic
activities (both intrinsic, for example, peptidyltransfer-
ase activity, and extrinsic, for example, GTPase
stimulating activity), processivity, accuracy, speed,
localization and so on. The idea of selective forces
operating on heterogeneous populations of ribosomes
may apply at all biological levels and to all processes,
maximizing fitness and maintaining homeostasis in
different subcellular compartments, in different cells, in
response to differentiation programs (external stimuli)
and in the specialized niches presented by different
tissues and organs. Importantly, the notion of
“specialized ribosomes” is implicit in this model.
Furthermore, different individuals within a species
may harbor subtly different distributions of ribosomes,
setting the ground for the speciation process in the
event that groups become geographically or environ-
mentally separated. Additionally, from this point of
view, reducing the ability of the population of ribo-
somes to fully occupy the ribosome's functional space
or altering the homeostatic distribution of ribosomes
within or outside of this space could explain the genetic
findings discussed above and may in part underly the
tissue specificities and diseasepenetrancedifferences
observed in the ribosomopathies.
This line of reasoning is not without counterargu-
ments. For example, the existence of ribosomopathies
per se demonstrates that variations in ribosome
content can result in decreased fitness. However,
preventing one or even a few rRNAmodifications does
not result in demonstrable phenotypes [45,46], sug-
gesting that at least some degree of variability along
this axis is tolerable. Thus, rather than confirming the
monolithic ribosome view, this merely challenges us to
define limits for the range of “tolerable” ribosome
heterogeneity, that is, a ribosomal “habitable zone” (to
borrow a term from Astronomy). Importantly, a deeper
understanding of the selective pressures exerted on
ribosomes in different environments may enable
application of quantitative modeling approaches [47]
to this field. From this point of view, ribosomopathies
may be used as indicators of the boundaries of the
habitable zone. The field of ribosomopathies also
reveals our ignorance with regard to the importance of
ribosomal protein gene dosage on cellular homeosta-
sis. For example, ribosomal stress is associated with
changes in ribosomal protein availability, both within
and outside of the context of the ribosome (reviewed in
Refs. [48–52]). It is possible that ribosomal protein
dosage may be epistatically controlled via imprinting;
for example, differences in local chromatin structure
between maternal and paternal copies of the same
chromosome may affect the expression of ribosomal
protein genes. Expanding upon this, while it is well
known that eukaryotic genomes harbor hundreds of
copies of rDNA genes, little is known regarding theirallelism, nor do we know anything about their
differential expression. Germane to this, studies in
yeast revealed that over-expression of different
naturally occurring alleles of 5S rRNA can affect
translational fidelity [53]. Indeed, it is possible that
epistatic control of ribosomal protein and rRNA gene
expression may provide a buffering mechanism, for
example, enabling a species to respond to environ-
mental changes more quickly than allowed by natural
rates of mutation.
The Challenge of Identifying Specialized
Ribosomes: Genetics Predicts,
Biochemistry Confirms
As discussed above, there is a steadily growing trove
of genetic evidence supporting the specialized ribo-
some hypothesis. The problem is that genetics is a
subtractiveprocess: identifying the specific functionof a
special ribosome in an assay system containing n − 1
ribosomes will at best lead to inferential conclusions.
Indeed, we are fortunate that these systems actually
yield phenotypes (although it should be cautioned that
phenotypic changes could also be indicative of extra--
ribosomal function for ribosomal proteins; e.g., seeRef.
[54]). Thus, while the author considers himself to be a
card carrying geneticist, biochemical and biophysical
approaches hold the greatest promise for providing
definitive evidence for the existence of specialized
ribosomes.
Extraordinary claims require extraordinary evi-
dence. In this regard, demonstration of specialized
ribosomesmust satisfy the “one enzyme, one (set of)
substrate(s)” standard. To this end, three barriers
must be overcome: (1) homogenization, (2) charac-
terization and (3) substrate matching (see Box 1).
Homogenization entails separating one type of
ribosome from all others. Classically, this is performed
by either additive or subtractive approaches. The
additive approach requires generating homologous
ribosomes by reconstituting them from purified re-
combinant proteins and rRNAs. While this has been
achieved for some bacterial species [55] and, indeed,
“specialized” (drug-resistant) ribosomes have been so
assembled [56], tales of the many failed attempts to
replicate this tactic with eukaryotic ribosomes have
achieved near-legendary status in the ribosome
community's oral history. The other approach is
subtractive: purify an enzyme to homogeneity. While
affinity-tagging ribosomal proteins and rRNAs
methods are well developed [57,58], it is difficult to
envision how this could be used to purify one specific
type of naturally occurring ribosome. One alternative
to purifying homogeneous ribosomes from mixed
samples is to enhance resolution to the point where
single molecules can be observed and characterized.
Enhanced resolution will be technology driven.
Emerging technologies such as atomic-resolution
Box 1
Criteria for demonstration of “specialized ribo-
somes”: One enzyme, one substrate.
Demonstrate that one specific type of ribo-
some is optimized for one specific function.
Three barriers to overcome:
(1) Homogenization
(a) Classic approaches:
Additive (reconstitution)
Subtractive (purification)
(b) New technologies:
Single-molecule cryo-electron
microscopy
Femtosecond X-ray crystallography
High-throughput rRNA mod-seq
High-resolution proteomics
(2) Characterization
(a) Structural
(b) Biochemical
(c) Molecular
(d) Cellular
(3) Substrate identification and validation.
Substrates include:
(a) Specific mRNAs, tRNAs and
other RNAs
(b) Translation-associated factors
(c) Subcellular localization factors
(d) Specific translational profiles
(immunoribosomes, fidelity, etc.)
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crystallography [60] may enable visualization of
individual ribosomes, thus allowing structural differ-
ences (and, in the latter case, different dynamic
properties) to be discerned. Alternatively, emerging
technologies are beginning to allow discernment of
differences in the compositions of ribosomes in bulk
samples isolated from different types of cells or cells
subjected to different external challenges.For example,
high-throughput rRNA sequencing (RiboMeth-seq)
was used to reveal that 2′-O-methylation and pseu-
do-uridylation are sub-stoichiometric [61]; such hetero-
geneity may be indicative of specialized ribosomes
[62]. Advances in mass spectrometry are also begin-
ning to enable identification of differences among
populations of ribosomes isolated from different cells
and tissues [9,63–67].
Once homogenized, ribosomes must be charac-
terized. As shown, in Fig. 1, this may be achieved
along many different axes including (a) structural
properties, (b) biochemical properties (e.g., affinities
for various ligands, catalytic properties, decodingaccuracy, speed and processivity) and (c) cellular
properties (e.g., subcellular localization, cell type
and developmental stage expression). As discussed
above, the emerging cryo-electron microscopy
and femtosecond X-ray crystallography appear to
be emerging as the best ways to identify unique
structural properties. Single-molecule translation
systems [68–72] currently hold the best promise for
matching individual ribosomes' specific biochemical
activities. In contrast, cell-biology-based approaches
may be problematic because of the uncertainty
principle: methods used to identify unique ribosomes
may alter their properties.
The third and last challenge is substrate identifi-
cation and validation. “Substrate” can be either
narrowly or broadly defined. A narrow definition
may be limited to demonstrate that a specific type of
ribosome is optimized to translate a specific mRNA
or class of mRNAs. Slightly more broadly defined
substrates may include tRNA isoacceptor species or
different types of initiation, elongation, termination
and recycling factors. Even more broadly, unique
features that specify interactions with subcellular
localization factors may be considered. Lastly,
“substrate” may be intrinsic to the ribosome and its
interaction with features in specific mRNAs. For
example, “immunoribosomes” have been posited to
generate defective ribosomal products in specialized
subcellular compartments to enable efficient intracel-
lular antigen presentation with major histocompatibil-
ity complex class I molecules [73,74]. Additionally,
unpublishedobservations fromour laboratory suggest
that some ribosomes may be better than others at
recognizing stop codons and shifting reading frame in
response to specific cis-acting mRNA control
elements.
Plot twist: If you can't beat 'em, join 'em
Throughout this essay, the issue of specialized
ribosomes has been discussed from the point of
view of a classical “discovery science”. This conjures
up the late 19th century romantic image of heroic
explorers braving the hazards of nature in the quest
to unveil its mysteries. However, as discoveries have
accumulated and we have gained deeper under-
standing of nature's inner workings, we are increas-
ingly adroit in manipulating nature to our own ends.
This is the view of the technologist, who does not
care whether or not something naturally exists as
long as it can be synthesized. Genetic methods have
long been used to create “designer” ribosomes in
living cells. For example, pure populations of mutant
ribosomes can be synthesized in cells lacking
chromosomal rDNA genes [75,76], and orthogonal
systems have been constructed enabling one type of
synthetic ribosome to utilize one specific isoacceptor
tRNA [77,78]. A fascinating recent technological
breakthrough was the development of a
2192 Perspective: Pathways to Specialized Ribosomes“monopartite” ribosome in which the subunits are
tethered together [79]; this will allow the engineering
of ribosomes with new functions and the develop-
ment of orthogonal genetic systems. Thus, should
the process of discovering and validating specialized
ribosomes prove too onerous, adopting the techno-
logist's mindset may be just the recipe for maintain-
ing one's sanity.Acknowledgements
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